Ignite Creation Date:
2024-05-06 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 2:29 PM
Study NCT ID:
NCT05317078
Status:
TERMINATED
Last Update Posted:
2024-07-08
First Post:
2022-03-30
Brief Title:
A Phase 1 Safety Tolerability and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer Epithelial Ovarian Cancer and Other Malignant Solid Tumor Indications
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-30
First Submit QC Date:
March 30 2022
Study First Post Date:
2022-04-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-05
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL